KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Q3 2025 value amounting to $1.1 million.

  • Rigel Pharmaceuticals' Interest & Investment Income rose 15741.18% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 3167.26%. This contributed to the annual value of $2.1 million for FY2024, which is 792.25% down from last year.
  • Rigel Pharmaceuticals' Interest & Investment Income amounted to $1.1 million in Q3 2025, which was up 15741.18% from $753000.0 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Interest & Investment Income ranged from a high of $1.1 million in Q3 2025 and a low of $1000.0 during Q1 2021
  • Its 5-year average for Interest & Investment Income is $396473.7, with a median of $429000.0 in 2022.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 9972.07% in 2021, then surged by 258125.0% in 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' Interest & Investment Income (Quarter) stood at $16000.0 in 2021, then skyrocketed by 2581.25% to $429000.0 in 2022, then surged by 58.04% to $678000.0 in 2023, then decreased by 23.01% to $522000.0 in 2024, then skyrocketed by 109.58% to $1.1 million in 2025.
  • Its Interest & Investment Income stands at $1.1 million for Q3 2025, versus $753000.0 for Q2 2025 and $591000.0 for Q1 2025.